AbbVie Inc.
ABBV · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 58.05B | 40.64B | 18.12B | 11.84B | 6.65 |
| 2023 FY | 54.32B | 33.90B | 12.76B | 4.86B | 2.73 |
| 2024 FY | 56.33B | 39.43B | 9.14B | 4.28B | 2.40 |
| 2025 FY | 61.16B | 42.96B | 20.09B | 4.23B | 2.37 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 138.81B | 121.52B | 9.20B | 64.19B | 17.25B |
| 2023 FY | 134.71B | 124.31B | 12.81B | 60.12B | 10.36B |
| 2024 FY | 135.16B | 131.80B | 5.52B | 67.84B | 3.33B |
| 2025 FY | 133.96B | 137.19B | 5.23B | 69.07B | -3.27B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 24.94B | -695.00M | 24.25B | -10.04B | -545.00M |
| 2023 FY | 22.84B | -777.00M | 22.06B | -10.54B | 3.61B |
| 2024 FY | 18.81B | -974.00M | 17.83B | -11.03B | -7.29B |
| 2025 FY | 19.03B | -1.21B | 17.82B | -11.66B | -295.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 286.21B | 341.20B | — | — | — |
| 2023 FY | 273.99B | 321.29B | — | — | — |
| 2024 FY | 314.35B | 376.67B | — | — | — |
| 2025 FY | 406.80B | 470.64B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 15.42B | 11.08B | 4.89B | 938.00M | 0.53 |
| 2025 Q3 | 15.78B | 10.47B | 1.90B | 186.00M | 0.10 |
| 2025 Q4 | 16.62B | 12.07B | 5.81B | 1.82B | 1.02 |
| 2026 Q1 | 15.00B | 10.78B | 4.73B | 699.00M | 0.39 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 137.18B | 137.32B | 6.47B | 70.48B | -183.00M |
| 2025 Q3 | 133.90B | 136.50B | 5.63B | 68.74B | -2.64B |
| 2025 Q4 | 133.96B | 137.19B | 5.23B | 68.87B | -3.27B |
| 2026 Q1 | 136.46B | 108.96B | 9.39B | 72.86B | 27.50B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 5.15B | -269.00M | 4.88B | -2.91B | 1.29B |
| 2025 Q3 | 7.02B | 504.00M | 7.53B | -2.91B | -838.00M |
| 2025 Q4 | 5.22B | -329.00M | 4.89B | -2.91B | -400.00M |
| 2026 Q1 | 3.83B | -265.00M | 3.56B | -3.09B | 4.16B |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 328.92B | 392.93B | — | — | — |
| 2025 Q3 | 410.29B | 473.40B | — | — | — |
| 2025 Q4 | 406.80B | 470.45B | — | — | — |
| 2026 Q1 | 385.80B | 449.26B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |